1. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice.
- Author
-
O'Hara JR, Feener TD, Fischer CD, and Buret AG
- Subjects
- Animals, Campylobacter Infections metabolism, Campylobacter Infections pathology, Campylobacter jejuni immunology, Cell Line, Colitis chemically induced, Colitis pathology, Colon microbiology, Colon pathology, DNA, Bacterial metabolism, Dextran Sulfate, Epithelial Cells microbiology, Epithelial Cells pathology, Interleukin-17 biosynthesis, Interleukin-8 biosynthesis, Interleukin-8 metabolism, Intestinal Mucosa immunology, Intestinal Mucosa microbiology, Intestinal Mucosa pathology, Mice, Mice, Inbred C57BL, Signal Transduction, Toll-Like Receptor 9 agonists, Campylobacter Infections immunology, Campylobacter jejuni metabolism, Campylobacter jejuni pathogenicity, Colitis physiopathology, Colon immunology, Epithelial Cells immunology, Toll-Like Receptor 9 metabolism
- Abstract
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation associated with a dysregulated immune response to commensal bacteria in susceptible individuals. The relapse of IBD may occur following an infection with Campylobacter jejuni. Apical epithelial Toll-like receptor 9 (TLR9) activation by bacterial DNA is reported to maintain colonic homeostasis. We investigated whether a prior C. jejuni infection disrupts epithelial TLR9 signaling and increases the severity of disease in a model of mild dextran sulfate sodium (DSS) colitis in mice. In a further attempt to identify mechanisms, T84 monolayers were treated with C. jejuni followed by a TLR9 agonist. Transepithelial resistance (TER) and dextran flux across confluent monolayers were monitored. Immunohistochemistry, Western blotting, and flow cytometry were used to examine TLR9 expression. Mice colonized by C. jejuni lacked any detectable pathology; however, in response to low levels of DSS, mice previously exposed to C. jejuni exhibited significantly reduced weight gain and increased occult blood and histological damage scores. Infected mice treated with DSS also demonstrated a significant reduction in levels of the anti-inflammatory cytokine interleukin-25. In vitro studies indicated that apical application of a TLR9 agonist enhances intestinal epithelial barrier function and that this response is lost in C. jejuni-infected monolayers. Furthermore, infected cells secreted significantly more CXCL8 following the basolateral application of a TLR9 agonist. Surface TLR9 expression was reduced in C. jejuni-infected monolayers subsequently exposed to a TLR9 agonist. In conclusion, infection by C. jejuni disrupts TLR9-induced reinforcement of the intestinal epithelial barrier, and colonization by C. jejuni increases the severity of mild DSS colitis.
- Published
- 2012
- Full Text
- View/download PDF